tim@emorningcoffee.comMar 147 minAnti-obesity medications part 2: the duopoly of Eli Lilly and Novo NordiskEli Lilly (LLY) and Novo Nordisk (NVO) have been large players for decades in the market for diabetes medications and are currently...
tim@emorningcoffee.comMar 127 minAnti-obesity medications part 1: the market for anti-obesity drugsThis article is being published in instalments, of which this is the first, for context. INTRODUCTION Two macrotrends have been drivers...